Water vapor thermal therapy for indwelling urinary catheter removal in frail patients

Tadrist, Abel; Baboudjian, Michael; Bah, Mamadou Bissiriou; Alegorides, C.; Bottet, F.; Arroua, F.; Eghazarian, C.; Fourmarier, M.

doi:10.1007/s11255-022-03408-w

Cited by 10 publications

(10 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a small, single-center study consisting of 24 men with a median age of 77 (IQR 67–86), who were considered frail and catheter dependent, the efficacy of water vapor thermal therapy was assessed. 28 After 1-year post-op, all patients maintained spontaneous voiding and did not require surgical retreatment. Only two adverse events occurred: one bleeding event that was treated with PAE; and another patient treated for prostatitis.…”

Section: Resultsmentioning

confidence: 83%

Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years – A Review of Published Literature

Codelia-Anjum,

Berjaoui,

Khondker

et al. 2023

CIA

View full text Add to dashboard Cite

Objective We set out to review studies reporting on the use of surgical intervention to treat Benign Prostatic Hyperplasia in elderly men ≥70 years of age. Methods A systematic literature search was conducted using Scopus, PubMed-MEDLINE, Cochrane, and Wiley Online Library databases including studies published between January 2012 through December 2022. This 10-year interval was chosen given the recent plethora of new modalities that have entered the BPH armamentarium, many of which have been marketed as appropriate for older and high-risk patients. The following database search words were used either individually or in conjunction: “BPH”, “elderly”, “surgical”, “ablation”, “resection”, “embolization”, and “aging”. Results We identified 28 studies for inclusion in this review. The pros and cons of these modalities are presented, specifically as applicable to an older and higher risk population. Conclusion There are a wide variety of surgical procedures available for surgically treating BPH in elderly men with varying states of health. Each of these comes with different risks and benefits, supporting that individualized approaches are important. Long-term data and further studies comparing modalities, specifically as regards the elderly and frail, would enhance our approaches to BPH treatment in this patient population.

show abstract

Section: Resultsmentioning

confidence: 83%

Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years – A Review of Published Literature

Codelia-Anjum,

Berjaoui,

Khondker

et al. 2023

CIA

View full text Add to dashboard Cite

show abstract

“…A retrospective study by Campobasso et al [20] included patients with a gland >80 ml and the authors concluded that prostate volume is not a predictive factor for urinary and sexual outcomes after Rezūm. A single-site prospective registry study of 24 patients treated with Rezūm included five patients with a gland of 80–120 ml, with favorable safety and effectiveness outcomes for the entire cohort [21] . A retrospective study ( n = 211) that included 42 patients with a prostate ≥80 ml revealed that prostate volume ≥80 ml was associated with a higher risk of reoperation (odds ratio 4.29, 95% CI 1.15–15.1; p = 0.024), with 9.5% of the large-gland cohort undergoing retreatment (4/42) [22] .…”

Section: Discussionmentioning

confidence: 99%

Prospective Trial of Water Vapor Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia in Subjects with a Large Prostate: 6- and 12-month Outcomes

Woo,

Levin,

Cantrill

et al. 2023

European Urology Open Science

View full text Add to dashboard Cite

“…Mean patient age ranged between 71. and 144.3 mL [92, 214.9], respectively). Four studies, 12,22,29,36 one evaluating PAE and Rezum 12 and the other three evaluating Rezum, 22,29,36 reported outcomes for only patients with chronic urinary retention (Table 2).…”

Section: Patient Characteristicsmentioning

confidence: 99%

“…Outcomes for a total of 297 geriatric patients with chronic urinary retention across nine studies 10,12,22,[27][28][29]35,36,38 were reported: 32 with PAE, 209 with Rezum, and 56 with GreenLight.…”

Section: Efficacymentioning

confidence: 99%

“…54 Our review also explored the outcomes of MISTs in geriatric patients with baseline urinary retention. However, only nine studies 10,12,22,[27][28][29]35,36,38 with 32 patients treated with PAE, 209 treated with Rezum, and 56 with GreenLight met the inclusion criteria. These three MISTs successfully achieved catheter independence following treatment in the majority of patients.…”

Section: Quality Appraisalmentioning

confidence: 99%

See 1 more Smart Citation

Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review

Abid,

Piperdi,

Babar

et al. 2024

The Prostate

View full text Add to dashboard Cite

BackgroundGeriatric patients, prone to adverse events (AEs) and low compliance with drugs, may benefit from minimally invasive surgical therapies (MISTs) for managing benign prostatic hyperplasia (BPH). We evaluated the efficacy, safety, and procedural characteristics of MISTs in geriatric patients with BPH.MethodsPubMed/MEDLINE database was systematically searched for relevant articles through October 1, 2023. Eligible studies focused on geriatric patients (≥65 years) with BPH who were treated with MISTs and evaluated follow‐up surgical, micturition, and/or sexual outcomes. Studies were included if there was separate reporting for age subgroups ≥65 years, or if the mean age minus standard deviation was ≥65 years, or if the first quartile was ≥65 years.ResultsOut of 292 screened studies, 32 (N = 3972 patients) met inclusion criteria and assessed prostatic artery embolization (PAE), Rezum, GreenLight, holmium laser enucleation of the prostate (HoLEP), thulium laser enucleation of the prostate (ThuLEP), diode laser enucleation of the prostate (DiLEP), and Aquablation. Except for Rezum, all MISTs required a planned overnight stay. While PAE and Rezum could be performed under local anesthesia, the other MISTs needed general or spinal anesthesia. Postoperative catheterization duration was longest for PAE (median 14 days) and Rezum (21 days) and shortest for GreenLight (1.9 days). At 12 months postoperatively, all MISTs exhibited significant percent changes in International Prostate Symptom Score (median −69.9%) and quality of life (median −72.5%). Clavien‐Dindo Grade 1 AEs ranged widely, with PAE (5.8%–36.8%), Rezum (0%–62.1%), and GreenLight (0%–67.6%) having the largest range, and HoLEP (0%–9.5%), ThuLEP (2%–6.9%), and DiLEP (5%–17.5%) having the smallest. PAE, Rezum, DiLEP, and Aquablation reported no significant changes in the International Index of Erectile Function.ConclusionsAlthough all the MISTs reviewed in this study effectively treat BPH in geriatric patients, differences in procedural characteristics and safety profiles across MISTs were considerable. Physicians should use shared decision‐making processes, considering risks and patient characteristics, when choosing a suitable treatment option for their patients.

show abstract

Water vapor thermal therapy for indwelling urinary catheter removal in frail patients

Cited by 10 publications

References 17 publications

Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years – A Review of Published Literature

Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years – A Review of Published Literature

Prospective Trial of Water Vapor Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia in Subjects with a Large Prostate: 6- and 12-month Outcomes

Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review

Contact Info

Product

Resources

About